Unknown

Dataset Information

Removal of group B streptococci colonizing the vagina and oropharynx of mice with a bacteriophage lytic enzyme.


ABSTRACT: Group B streptococci (GBS) are the leading cause of neonatal meningitis and sepsis worldwide. The current treatment strategy is limited to intrapartum antibiotic prophylaxis in pregnant women to prevent early-onset neonatal diseases, but considering the potential for antibiotic resistance, the risk of losing control over the disease is high. To approach this problem, we have developed a bacteriophage (phage) lytic enzyme to remove colonizing GBS. Bacteriophage muralytic enzymes, termed lysins, are highly evolved molecules designed to degrade the cell wall of host bacteria to release phage particles from the bacterial cytoplasm. Several different lysins have been developed to specifically kill bacterial pathogens both on mucosal surfaces and in blood and represent a novel approach to contro

SUBMITTER: Cheng Q 

PROVIDER: S-EPMC538902 | biostudies-literature | 2005 Jan

REPOSITORIES: biostudies-literature